Teva (TEVA) in talks to buy Barr Pharmaceuticals Inc. (BRL) for about $7 billion - WSJ
Tweet Send to a Friend
Teva (Nasdaq: TEVA) in talks to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
